IMTX net incomeFY2025-€196.45M
IMTX net income was -€196.45M for fiscal 2025 (ended Dec 31, 2025), compared with €15.22M in fiscal 2024.
Immatics N.V. (IMTX) financials
For fiscal 2025 (ended Dec 31, 2025), Immatics N.V. reported -€196.45M of net income. Figures are in EUR, the currency of its SEC filings.
- Net income, FY2025
- -€196.45M
- Free cash flow, FY2025
- -€183.18M
- EPS, diluted, FY2025
- -€1.61
- Cash
- €345.92M
FY2018FY2025
FY2018FY2025
IMTX revenue and earnings growth
IMTX EPSFY2025-€1.61
IMTX diluted EPS was -€1.61 for fiscal 2025 (ended Dec 31, 2025), compared with €0.14 in fiscal 2024.
IMTX free cash flowFY2025-€183.18M
IMTX free cash flow was -€183.18M for fiscal 2025 (ended Dec 31, 2025), compared with -€174.30M in fiscal 2024.
Income statement
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Research and development | €183.83M | €148.08M | €118.66M | €106.78M | €87.57M | €67.08M | €40.09M | €33.97M |
| Selling, general and admin | €51.18M | €46.45M | €38.20M | €36.12M | €33.81M | €34.19M | €11.76M | €7.67M |
| Operating income | -€182.02M | -€38.62M | -€101.72M | €29.95M | -€86.29M | -€69.72M | -€33.01M | -€34.41M |
| Interest expense | €946.0K | €886.0K | €831.0K | €1.04M | €566.0K | €289.0K | €264.0K | €161.0K |
| Pre-tax income | -€198.44M | €21.35M | -€96.99M | €42.04M | -€93.33M | -€211.84M | -€32.49M | -€32.35M |
| Income tax | -€1.99M | €6.13M | -€2.35M | €14.33M | €0 | €0 | €0 | €0 |
| Net income | -€196.45M | €15.22M | -€94.65M | €27.70M | -€93.33M | -€211.28M | -€31.57M | -€31.44M |
| EPS, basic | -€1.61 | €0.14 | -€1.18 | €0.41 | -€1.48 | -€4.40 | - | - |
| EPS, diluted | -€1.61 | €0.14 | -€1.18 | €0.40 | -€1.48 | -€4.40 | - | - |
| Diluted shares | 122.3M | 106.8M | 80.5M | 68.8M | 62.9M | 48.0M | 33.1M | 33.1M |
Balance sheet
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | €345.92M | €236.75M | €218.47M | €148.52M | €132.99M | €207.53M | €103.35M | €39.37M |
| Current assets | €504.01M | €629.55M | €449.37M | €377.15M | €152.21M | €238.99M | €124.00M | - |
| Total assets | €562.34M | €696.15M | €509.96M | €407.82M | €174.65M | €254.65M | €134.28M | - |
| Current liabilities | €43.01M | €67.99M | €156.55M | €106.45M | €95.15M | €77.48M | €69.30M | - |
| Total liabilities | €78.24M | €121.30M | €292.35M | €204.47M | €150.58M | €167.26M | €175.11M | - |
| Shareholders' equity | €484.10M | €574.84M | €217.62M | €203.35M | €24.06M | €87.39M | -€40.84M | -€9.17M |
Cash flow
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -€176.63M | -€158.03M | €18.23M | €100.13M | -€84.75M | -€80.70M | €70.97M | €20.68M |
| Capital expenditures | €6.56M | €16.27M | €30.80M | €5.74M | €5.11M | €7.42M | €2.14M | €429.0K |
| Free cash flow | -€183.18M | -€174.30M | -€12.57M | €94.39M | -€89.85M | -€88.12M | €68.82M | €20.25M |
| Investing cash flow | €204.79M | -€152.39M | -€31.39M | -€209.79M | €7.49M | -€15.95M | -€5.06M | -€13.51M |
| Financing cash flow | €97.35M | €319.68M | €84.52M | €123.71M | -€2.61M | €207.88M | -€1.86M | €23.65M |
| Stock-based compensation | - | - | - | - | - | €45.0K | €700.0K | €1.36M |
| Depreciation and amortization | €12.40M | €12.22M | €7.23M | €6.97M | €5.26M | €4.42M | €3.86M | €2.18M |
Key ratios
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Return on equity | -40.6% | 2.6% | -43.5% | 13.6% | -387.9% | -241.8% | - | - |
| Return on assets | -34.9% | 2.2% | -18.6% | 6.8% | -53.4% | -83.0% | -23.5% | - |
| Current ratio | 11.72 | 9.26 | 2.87 | 3.54 | 1.60 | 3.08 | 1.79 | - |
Income statement
| Line item | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|
| Pre-tax income | €43.27M | -€2.35M | -€17.85M | -€1.72M |
| Income tax | €2.52M | €2.95M | €140.0K | €518.0K |
| Net income | €40.76M | -€5.30M | -€17.99M | -€2.24M |
| EPS, basic | €0.38 | -€0.05 | -€0.17 | -€0.02 |
| EPS, diluted | €0.42 | -€0.08 | -€0.17 | -€0.03 |
| Diluted shares | - | 110.3M | 103.1M | 105.9M |
Balance sheet
| Line item | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|
| Cash and equivalents | €236.75M | €189.20M | €158.14M | €122.09M |
| Current assets | €629.55M | - | - | - |
| Total assets | €696.15M | €577.23M | €626.97M | €653.13M |
| Current liabilities | €67.99M | €128.91M | €149.55M | €149.10M |
| Total liabilities | €121.30M | €198.06M | €245.70M | €258.99M |
| Shareholders' equity | €574.84M | €379.17M | €381.26M | €394.13M |
Cash flow
| Line item | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|---|---|
| Operating cash flow | -€58.48M | -€33.73M | -€33.22M | -€32.60M |
| Investing cash flow | -€47.41M | €67.01M | €69.83M | -€241.82M |
| Financing cash flow | €146.36M | -€753.0K | -€566.0K | €174.65M |
Key ratios
Source: XBRL data Immatics N.V. files with the SEC, latest filing dated Mar 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
IMTX peers
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| IMTX | - | - | -€196.45M | - | $962.1M |
| AMGN | $38.90B | +8.2% | $9.39B | 24.1% | $251.65B |
| GILD | $30.99B | +6.5% | -$3.86B | -12.5% | $210.01B |
| MRNA | $2.52B | +13.1% | -$2.79B | -110.5% | $107.39B |
| ARGX | $4.25B | +88.6% | $1.29B | 30.4% | $59.72B |
| RVMD | $0 | - | -$1.13B | - | $43.29B |
| BIIB | $10.30B | +2.3% | $347.50M | 3.4% | $37.67B |
| BNTX | €2.87B | +4.3% | -€1.14B | -39.6% | $21.98B |
| EXEL | $2.50B | +9.1% | $885.14M | 35.5% | $17.51B |
IMTX FAQ
6 questionsIs IMTX profitable?
No. Immatics N.V. reported a net loss of €196.45M for fiscal 2025 (ended Dec 31, 2025).How much cash and debt does IMTX have?
Immatics N.V. reported €345.92M in cash and cash equivalents on its most recent balance sheet in SEC filings.What is IMTX free cash flow?
Immatics N.V. generated -€183.18M of free cash flow for fiscal 2025 (ended Dec 31, 2025), which is operating cash flow of -€176.63M less capital expenditures.What is IMTX earnings per share?
Diluted earnings per share were -€1.61 for fiscal 2025 (ended Dec 31, 2025), from SEC filings, restated for any stock split those filings show.When did IMTX last report financial results?
The latest statements here come from Immatics N.V.'s 20-F filed on Mar 5, 2026, covering the period ended Dec 31, 2025.Where does this IMTX financial data come from?
Quantisnow builds these statements from the structured XBRL data Immatics N.V. files with the SEC. It is provided for information only and is not investment advice.